BIOGEN INC.

13D and 13G Filings

13D/G filings
13D on 2 securities
CIK
0000875045
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 2 securities · may seek to influence control
Apellis Pharmaceuticals, Inc. 13D/A
APLS · 03753U106
0% 5/14/2026
Event 5/14/2026
Sage Therapeutics, Inc. 13D/A
SAGE · 78667J108
0% 7/30/2025
Event 7/30/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.